跳至主要内容
临床试验/ACTRN12622000360718
ACTRN12622000360718尚未招募未知

The effect of nutrition supplementation before and after revascularisation procedure in people with peripheral arterial disease compare to usual care: The Peri-operative nutrition in Peripheral Arterial Disease (PPAD) trial.

Abbott Medical Australia Pty Ltd0 个研究点目标入组 264 人开始时间: 2022年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
264

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inpatients and outpatients at Flinders Medical Centre who are scheduled to undergo open or endovascular revascularisation for PAD.

排除标准

  • Patients will be excluded if they are: 1) <18 years old; 2) have been diagnosed with a terminal illness; 3) are unable to communicate effectively to provide informed consent such as those with cognitive impairment; 4) have a diagnosis of galactosemia (a contra-indication to immuno-nutrition supplement) or 5) have a fluid restriction.

研究者

发起方
Abbott Medical Australia Pty Ltd

相似试验